LENZ Therapeutics, Inc. (LENZ) Misses Q4 EPS by 116c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q4 EPS of ($1.16). Revenue for the quarter came in at $1.59 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• UBS Upgrades SD Guthrie (SDG:MK) to Buy
• JPMorgan Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral